Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐term GnRH Agonist Therapy Before in Vitro Fertilisation (IVF) for Improving Fertility Outcomes in Women With Endometriosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439282/all/repview. Accessed 01 May 2024.
Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439282/all/repview. Accessed May 1, 2024.
Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439282/all/repview
Long‐term GnRH Agonist Therapy Before in Vitro Fertilisation (IVF) for Improving Fertility Outcomes in Women With Endometriosis [Internet]. In: Cochrane Abstracts. [cited 2024 May 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439282/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
ID - 439282
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439282/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -